Gemsar Rtu 1 g Injection

Description

Injection de Gemsar RTU 1 g is a sterile, ready-to-use solution containing Gemcitabine Hydrochloride as the active pharmaceutical ingredient. Gemcitabine is a nucleoside analog that works by interfering with DNA synthesis, thereby inhibiting the growth of cancer cells. It is primarily used in the treatment of various types of cancer, including pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer, often in combination with other chemotherapy agents. The dosage and administration should be strictly determined by a qualified healthcare professional based on the patient’s condition, response to treatment, and other individual factors. This medication is administered intravenously. Patients should inform their doctor about any pre-existing medical conditions, especially kidney or liver impairment, and any other medications they are taking. Common side effects may include fatigue, nausea, vomiting, fever, and myelosuppression. Store at room temperature (20°C to 25°C) and protect from light. Do not refrigerate or freeze.